Clinical Study

Topical 100% Serum Eye Drops for Treating Corneal Epithelial Defect after Ocular Surgery

Table 3

Summary of 11 patients unresponsive to serum eye drops treatment.

DiagnosisIndicationNumber (%)Increased dosageFurther treatment

Alkali injuriesTectonic PK1 (0.55)100% ASE q 1 hrAMT with tarsorrhaphy
Ocular cicatricial pemphigoidTherapeutic PK1 (0.55)100% AlloSE q 1 hrAMT with tarsorrhaphy
Severe fungal keratitisTherapeutic PK2 (1.10)100% ASE q 1 hrAMT (2), Gunderson conjunctival flap (1)
Stevens-Johnson syndrome
(i) Corneal ulcer failed medical therapyTherapeutic PK2 (1.10)100% ASE q 1 hrAMT with tarsorrhaphy (2)
(ii) Corneal melting and perforationTherapeutic PK2 (1.10)100% ASE q 1 hrAMT with tarsorrhaphy (1), evisceration (1)
(iii) Post-Boston keratoprosthesis surgeryOptical3 (1.66)
100% ASE q 1 hrRegraft, glue adhesion, and tarsorrhaphy (2), evisceration (1)

ASE: autologous serum eye drops; AlloSE: allogeneic serum eye drops; PK: penetrating keratoplasty; AMT: amniotic membrane transplantation.